A BILL 
To amend the United States-Mexico Border Health Commis-
sion Act, with respect to preparedness for COVID–19 
and other infectious diseases in the border region, and 
for other purposes. 
Be it enacted by the Senate and House of Representa-
1
tives of the United States of America in Congress assembled, 
2
SECTION 1. SHORT TITLE. 
3
This Act may be cited as the ‘‘Binational Health 
4
Strategies Act of 2020’’. 
5
01:46 Nov 01, 2020
H8599
2 
•HR 8599 IH
SEC. 2. UNITED STATES-MEXICO BORDER HEALTH COMMIS-
1
SION INFECTIOUS DISEASE PREPAREDNESS. 
2
The United States-Mexico Border Health Commis-
3
sion Act (22 U.S.C. 290n et seq.) is amended by inserting 
4
after section 5 (22 U.S.C. 290n–5) the following: 
5
‘‘SEC. 5A. INFECTIOUS DISEASE PREPAREDNESS. 
6
‘‘(a) COVID–19 RESPONSE.—Not later than 120 
7
days after the date of the enactment of this section, and 
8
annually thereafter (for as long as the Commission, acting 
9
with the participation of members representing both the 
10
United States and Mexican sections, determines is nec-
11
essary), the Commission shall submit to Congress a report 
12
on the United States-Mexico Border Area’s response (be-
13
ginning on February 1, 2020) to COVID–19, including 
14
with respect to testing, contact tracing, and other infection 
15
prevention and control measures carried out in the United 
16
States-Mexico Border Area, in both the United States and 
17
Mexico. 
18
‘‘(b) COVID–19 BINATIONAL PLAN.— 
19
‘‘(1) IN
GENERAL.—Not later than 60 days 
20
after the date of the enactment of this section, the 
21
Commission (acting with the participation of mem-
22
bers representing both the United States and Mexi-
23
can sections) shall develop, and publish on a public 
24
website of the Commission, a binational strategic 
25
01:46 Nov 01, 2020
H8599
3 
•HR 8599 IH
plan that addresses, with respect to COVID–19, 
1
how— 
2
‘‘(A) the United States-Mexico Border 
3
Area should strengthen its response to COVID– 
4
19, with a focus on testing, contact tracing, and 
5
other infection prevention and control measures; 
6
‘‘(B) the effect of COVID–19 on the eco-
7
nomic conditions in the United States-Mexico 
8
Border Area may be mitigated; 
9
‘‘(C) the sharing of relevant health data, 
10
with respect to COVID–19, including testing 
11
and positivity rates, between health agencies 
12
within the United States-Mexico Border Area 
13
can be strengthened; and 
14
‘‘(D) a vaccine should be disbursed 
15
throughout the United States-Mexico Border 
16
Area, taking into account the various vulnerable 
17
populations in the region. 
18
‘‘(2) IMPLEMENTATION.—Not later than 60 
19
days after the date of the enactment of this section, 
20
the Commission (acting with the participation of 
21
members representing both the United States and 
22
Mexican sections) shall develop, and publish on a 
23
public website of the Commission, what actions Fed-
24
eral agencies will take within the United States sec-
25
01:46 Nov 01, 2020
H8599
4 
•HR 8599 IH
tion and agencies of the Government of Mexico will 
1
take within the Mexican section of the United 
2
States-Mexico Border Area to facilitate implementa-
3
tion of the plan under paragraph (1). At least once 
4
each year after the publication of such information, 
5
the Commission shall submit to Congress a report 
6
on actions taken by Federal agencies and agencies of 
7
the Government of Mexico to facilitate that imple-
8
mentation during the year covered by the report. 
9
‘‘(c) FUTURE INFECTIOUS DISEASE PLAN.— 
10
‘‘(1) IN GENERAL.—Not later than 180 days 
11
after the date of the enactment of this section, the 
12
Commission shall develop and publish a plan to pre-
13
pare and respond to infectious diseases (other than 
14
COVID–19) within the United States-Mexico Border 
15
Area. Such plan shall address how— 
16
‘‘(A) the United States-Mexico Border 
17
Area should strengthen its response to such in-
18
fectious diseases, with a focus on testing, con-
19
tact tracing, and other infection prevention and 
20
control measures; 
21
‘‘(B) the effect of such infectious diseases 
22
on the economic conditions in the United 
23
States-Mexico Border Area may be mitigated; 
24
01:46 Nov 01, 2020
H8599
5 
•HR 8599 IH
‘‘(C) the sharing of relevant health data, 
1
with respect to such infectious diseases, includ-
2
ing testing and positivity rates, between health 
3
agencies within the United States-Mexico Bor-
4
der Area can be strengthened; and 
5
‘‘(D) a vaccine should be disbursed 
6
throughout the United States-Mexico Border 
7
Area, taking into account the various vulnerable 
8
populations in the region. 
9
‘‘(2) UPDATES.—The Commission shall update 
10
the plan published under paragraph (1) at least once 
11
every 3 years for as long as the Commission, acting 
12
with the participation of members representing both 
13
the United States and Mexican sections, determines 
14
is necessary. 
15
‘‘(3) IMPLEMENTATION.—Not later than 60 
16
days after the date of the enactment of this section, 
17
the Commission (acting with the participation of 
18
members representing both the United States and 
19
Mexican sections) shall develop, and publish on a 
20
public website of the Commission, what actions Fed-
21
eral agencies will take within the United States sec-
22
tion and agencies of the Government of Mexico will 
23
take within the Mexican section of the United 
24
States-Mexico Border Area to facilitate implementa-
25
01:46 Nov 01, 2020
H8599
6 
•HR 8599 IH
tion of the plan under paragraph (1). At least once 
1
a year after the publication of such information, the 
2
Commission shall submit to Congress a report on ac-
3
tions taken by Federal agencies and agencies of the 
4
Government of Mexico to facilitate that implementa-
5
tion during the year covered by the report.’’. 
6
Æ 
01:46 Nov 01, 2020
H8599
